Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

Discover how UMass Memorial Medical Center's new North Pavilion facility is improving patient and caregiver experience while meeting community care needs.

"I am a women's health provider at a federally qualified health center and public hospital, and I've never been so scared for ...

Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ 6.17 billion in 2024 and an impressive US$ 9.02 billion by ...